Sanofi acquires Dynavax for $2.2B, boosting its vaccine portfolio with HEPLISAV-B and a shingles candidate. Click for my ...
Learn how risk-based pricing in credit markets affects interest rates and loan terms based on creditworthiness, and understand regulatory requirements like the 2011 rule.
JMUB's low risk profile results in a trailing yield of 3.2%, with minimal credit and interest rate risk but limited upside.
Learn what active risk is and how to calculate it. Understand the methods to evaluate active risk in portfolios and explore examples of funds outperforming benchmarks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback